Skip to content
Agentic OS
Menu

Intelligence / Services / Auditor Changes / Goldenwell Biotech, INC.

Auditchanged auditor (SEC 8-K)29 Sept 2026

Goldenwell Biotech, INC.

29 Sept 2026: Changed auditor (SEC 8-K) · Michael Gillespie & Associates, PLLC. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
29 Sept 2026
Ticker
GWLL
Sector
Manufacturing
Sic
2000
Items
4.01, 9.01
Location
Solon, OH
State
Ohio
Country
United States
SEC CIK
1800373
Reference
0001477932-26-005892
Former
Michael Gillespie & Associates, PLLC
Event
Auditor dismissed
Summary
(a) On September 27, 2026, Goldenwell Biotech, Inc. (the "Company") notified Michael Gillespie & Associates, PLLC ("Gillespie & Associates"), that the Company had dismissed Gillespie & Associates as the independent registered public accounting firm of the Company.
What this signal means

A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.

  1. Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
  2. 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Goldenwell Biotech, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.

Start free

More in Auditor dismissed

Auditor Changes

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.